A major international study involving 23,000 people has found concerning evidence about the impact of a range of common, everyday medications on the treatment outcomes for patients with breast cancer.

Adverse Childhood Experiences (ACEs) are common, as nearly three out of five people have experienced at least one ACE--yet most people have never heard of them. -- In its first ten months, ...

A new observational study compared the risk for severe gastrointestinal adverse events across dulaglutide, semaglutide, and ...

Longer-term exposure to testosterone therapy was associated with an increased risk for major adverse cardiovascular events among men.

Semaglutide, the active ingredient in Wegovy and Ozempic, lowers major cardiac event risk, regardless of how much weight a ...

Drilling for minerals deep in the ocean could have immense consequences on the tiny animals at the core of the vast ocean ...

A growing number of Americans are turning to therapy by text message, and new research suggests it can be just as effective ...

Jupiter Endovascular today announced positive results from the first-in-human study of its Vertex pulmonary embolectomy ...

A large French cohort study finds that pregnant women with systemic sclerosis face increased risks of preeclampsia, preterm ...

A study using mice has found high exposure to PFAS lowered the male's sperm count, decreased testosterone and disrupted ...

The biotech’s phase 3 delivered the hoped-for second biomarker hit, reporting an 82% decline in serum creatine kinase after ...

A "blesser" is typically an older, relatively wealthier man who provides a younger woman with money, gifts, school fees or ...